J&J JNJ announced plans to invest more than $55 billion in the United States over the next four years to boost manufacturing, R&D and technology in the country. This represents a 25% increase in investment compared to the previous four years. J&J believes that the U.S. economic impact of the increased U.S. investment will exceed $100 billion a year.
The investments begin with the groundbreaking of a high-tech 500,000-square-foot, state-of-the-art biologics manufacturing facility in North Carolina. J&J expects this facility to create 5,000 construction jobs and more than 500 permanent positions once operational.
In addition, the company will build three new advanced manufacturing facilities and expand several existing plans across its Innovative Medicine and MedTech businesses. The locations of the three facilities were not disclosed.
J&J’s shares have outperformed the industry year to date. The stock has risen 13.1% compared with 6.3% growth of the industry.
Image Source: Zacks Investment Research
Drugmakers are looking to ramp up U.S. investments after reports that Trump plans to impose tariffs on imports of pharmaceutical products in a bid to encourage domestic production.
Last month, Eli Lilly LLY announced plans to invest $27 billion in building four new manufacturing sites in the United States by 2025, bringing its total domestic manufacturing expansion commitments since 2020 to over $50 billion. The increased manufacturing investment can boost production capacity for Lilly’s medicines, particularly its popular GLP-1 products, Mounjaro and Zepbound.
Pfizer PFE may be the next in line to make a similar announcement. Earlier this month, the company’s chief executive officer (CEO) Albert Bourla, at a healthcare conference, said that Pfizer is prepared to move some of its overseas manufacturing to the United States amid the tariff threats.
J&J has a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Johnson & Johnson price-consensus-chart | Johnson & Johnson Quote
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
Pfizer Inc. (PFE) : Free Stock Analysis Report
Eli Lilly and Company (LLY) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。